Cargando…

Can We Understand the Clinical Biology of Gastric Cancer and Exploit it? May be, but It is a Challenge!

Detalles Bibliográficos
Autor principal:	Ajani, Jaffer A.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2007
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077914/ https://www.ncbi.nlm.nih.gov/pubmed/17932722 http://dx.doi.org/10.1245/s10434-007-9575-5

Ejemplares similares

Microbes and cancer geography: can we exploit recent lessons from the gut system to oral cancer context?
por: GARLET, Gustavo P., et al.
Publicado: (2014)

Clinical Proteomics: From Biological Sample to Clinical Exploitation
por: Lasonder, Edwin
Publicado: (2017)

Understanding Gastric Cancer Risk Factors: We Need to Close the Gap
por: Hwang, Joo Ha
Publicado: (2018)

Proteomic profiling of key signatures from gastric lesions to early gastric cancer
por: Fan, Yibo, et al.
Publicado: (2021)

The role of hedgehog signaling in gastric cancer: molecular mechanisms, clinical potential, and perspective
por: Xu, Yan, et al.
Publicado: (2019)

Recent trend in gastric cancer treatment in the USA
por: Harada, Kazuto, et al.
Publicado: (2018)

Neuroplasticity and Healthy Lifestyle: How Can We Understand This Relationship?
por: Begega, Azucena, et al.
Publicado: (2017)

Review of docetaxel in the treatment of gastric cancer
por: Tetzlaff, Eric D, et al.
Publicado: (2008)

Programmed death ligand‐1 expression in gastrointestinal cancer: Clinical significance and future challenges
por: Yamashita, Kohei, et al.
Publicado: (2020)

We May Develop Medications Effective Against COVID-19, but Can We Distribute Them Equitably?
por: Kersten, Daniel J., et al.
Publicado: (2020)

Treatment of Gastric Adenocarcinoma May Differ Among Hospital Types in the United States, a Report from the National Cancer Data Base
por: Reid-Lombardo, Kaye M., et al.
Publicado: (2007)

Targeted literature review of the global burden of gastric cancer
por: Casamayor, Montserrat, et al.
Publicado: (2018)

Recent advances in the management of gastric adenocarcinoma patients
por: Rogers, Jane E, et al.
Publicado: (2023)

Attenuation of YAP1 can potentially target cancer stem cells to overcome drug resistance
por: Harada, Kazuto, et al.
Publicado: (2018)

How can we exploit above–belowground interactions to assist in addressing the challenges of food security?
por: Orrell, Peter, et al.
Publicado: (2013)

Antimicrobial resistance and inappropriate use of antimicrobials: Can we rise to the challenge?
por: Chandy, Sujith J.
Publicado: (2015)

Can You Establish the Cause of This Patient's Shortness of Breath?
por: Trail, Allison, et al.
Publicado: (2023)

Can we better understand sudden cardiac death by including data from unwitnessed victims?
por: Tan, Hanno L, et al.
Publicado: (2021)

The challenge of the COVID-19 pandemic: what can we learn from history?
por: dos Santos, Vanessa Prado
Publicado: (2021)

Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy
por: Badgwell, Brian, et al.
Publicado: (2017)

Challenges and Prospects of Patient-Derived Xenografts for Cancer Research
por: Jin, Jiankang, et al.
Publicado: (2023)

Can We Efficiently Target HDAC in Cancer?
por: Kiesslich, Tobias, et al.
Publicado: (2022)

Lipids in cell biology: how can we understand them better?
por: Muro, Eleonora, et al.
Publicado: (2014)

We Know the Prognosis but can We Change It?
por: Bandopadhyay, Susruta
Publicado: (2021)

Individualized Treatment Effects: Machine Learning Can Revolutionize Observations, but Let’s Understand What We Are Observing
por: Mosier, Jarrod M.
Publicado: (2023)

Understanding the biology of urothelial cancer metastasis
por: Kobayashi, Takashi
Publicado: (2016)

Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer
por: Guan, Xiaoxiang, et al.
Publicado: (2009)

Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?
por: Baxevanis, Constantin N.
Publicado: (2023)

Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer
por: Derks, Sarah, et al.
Publicado: (2022)

Publication of clinical trial protocols – what can we learn?
por: Skogvoll, Eirik, et al.
Publicado: (2013)

We Can Dance If We Want To (with Safety Measures)
por: Carson, Susan
Publicado: (2022)

The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer
por: Guan, Xiaoxiang, et al.
Publicado: (2009)

Cancer in southeast Asia: can we do better?
por: The Lancet Regional Health – Southeast Asia
Publicado: (2023)

Liver Transplant Tolerance and Its Application to the Clinic: Can We Exploit the High Dose Effect?
por: Cunningham, Eithne C., et al.
Publicado: (2013)

COVID-19 Is Changing Our Understanding of the Neuroscience of Viral Infections: What We Can Do to Prepare for the Future?
por: Liow, Kore Kai, et al.
Publicado: (2022)

Changes we can believe in
por: Siegel, Vivian
Publicado: (2011)

Data we can trust
por: Jackson, Sarah, et al.
Publicado: (2022)

Challenging clinical and organizational scenarios in cardiovascular diseases during the SARS-CoV-2 pandemic in Poland. Can we do better?
por: Wojakowski, Wojciech, et al.
Publicado: (2020)

Can We Do More for ISIM?
por: Asscher, A. W., et al.
Publicado: (1979)

Understanding the Natural History of Bicuspid Aortic Valve: Are We Close to Understanding It?
por: Lee, Seung-Pyo
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_er54jfg0ql7qedpnfdtarkuiqs